You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
The Mosaic bioprosthesis is an evolution in durability and implantability, based on the proven platform of the Hancock™ II valve.
Contact UsThe Mosaic bioprosthesis — based on more than 30 years of Medtronic tissue-valve design expertise — is an excellent choice for surgeons looking for long-lasting durability, exceptional performance and implantability for aortic, mitral, and MICS procedures.
Published clinical experience demonstrates impressive long-term performance in all age groups. Additional factors that may contribute to durability are:
AOA™ anti-calcification tissue treatment
Our innovative Cinch™ implant system further capitalizes on the valve’s flexible stent to facilitate valve implantation, particularly through a tight sinotubular space. It also:
Our exclusive Physiologic Fixation* process mitigates biomechanical failures and promotes long-term valve durability by:
Valve dimensions and geometry facilitate future TAV-in-SAV replacements. This includes:
Order |
Valve Size |
Orifice Diameter |
Suture Ring |
Valve Height |
Aortic |
---|---|---|---|---|---|
|
(A) |
(B) |
(C) |
(D) |
(E) |
305C219 |
19 |
17.5 |
25.0 |
13.5 |
11.0 |
305C221 |
21 |
18.5 |
27.0 |
15.0 |
12.0 |
305C223 |
23 |
20.5 |
30.0 |
16.0 |
13.5 |
305C225 |
25 |
22.5 |
33.0 |
17.5 |
15.0 |
305C227 |
27 |
24.0 |
36.0 |
18.5 |
15.5 |
305C229 |
29 |
26.0 |
39.0 |
20.0 |
16.0 |
Order |
Valve Size |
Orifice |
Suture Ring |
Valve Height |
Aortic |
---|---|---|---|---|---|
|
(A) |
(B) |
(C) |
(D) |
(E) |
310C25 |
25 |
22.5 |
33.0 |
18.0 |
13.5 |
310C27 |
27 |
24.0 |
35.0 |
19.0 |
14.0 |
310C29 |
29 |
26.0 |
38.0 |
20.5 |
15.5 |
310C31 |
31 |
28.0 |
41.0 |
22.0 |
17.0 |
310C33 |
33 |
30.0 |
43.0 |
23.0 |
17.5 |
Order |
Valve Size |
Orifice |
Suture Ring |
Valve Height |
Aortic |
---|---|---|---|---|---|
|
(A) |
(B) |
(C) |
(D) |
(E) |
305U219 |
19 |
17.5 |
24.0 |
13.5 |
11.0 |
305U221 |
21 |
18.5 |
26.0 |
15.0 |
12.0 |
305U223 |
23 |
20.5 |
28.0 |
16.0 |
13.5 |
305U225 |
25 |
22.5 |
30.0 |
17.5 |
15.0 |
305U227 |
27 |
24.0 |
32.0 |
18.5 |
15.5 |
305U229 |
29 |
26.0 |
34.0 |
20.0 |
16.0 |
Order Number |
Description |
---|---|
T7308C |
Mosaic Aortic Sizers Tray |
T7615MSM |
Tray, Accessory, Mosaic, Mitral |
T7308U |
Tray, Accessory, Mosaic Ultra Aortic |
7308U |
Mosaic Ultra Aortic Sizers |
7639 |
Handle (234 mm length) pliant, without locknut to be used with Mosaic or Mosaic Ultra prostheses |
7639XL |
Handle (368 mm length) pliant, without locknut to be used with Mosaic or Mosaic Ultra prostheses |
7308C |
Mosaic Aortic Sizer Set |
7310 |
Mosaic Mitral Obturator Set (no handles, no tray) |
Training, education, and collaboration on the treatment of mitral and tricuspid valve disease.
Learn MoreNo clinical data is available which evaluates the long-term impact of the Physiologic Fixation process or the impact of AOA treatment in patients.
Equivalent to annulus diameter.
Rieß FC, Fradet G, Lavoie A, Legget M. Long-Term Outcomes of the Mosaic Bioprosthesis. Ann Thorac Surg. March 2018;105(3):763-769.